Researchers receive $17 million grant to fight opioid addiction in prisons

It’s estimated that more than 130 people die every day from opioid-related drug overdoses. Particularly at risk are people transitioning through the criminal justice system, many of whom may already be struggling with complex issues spanning mental health, family instability and job and housing insecurity.

In order to understand how best to reduce opioid addiction and overdoses in this vulnerable population in prisons and other justice settings, the University of Chicago Medicine has been awarded a five-year, $17 million grant from the National Institute on Drug Abuse.

Two internationally respected public health researchers at UChicago will lead the grant: infectious disease researcher  John Schneider, who has previously conducted public health and implementation science research with community members in the criminal justice setting; and urban public health researcher  Harold Pollack, who has extensively researched how to assist individuals with substance use disorders and behavioral health challenges within the criminal justice system.

"More than half of the people who use opioids end up in jail or some sort of correctional setting," said Schneider, a professor of medicine and public health sciences. "If we can engage the justice community around this problem, maybe we can make an impact."

"Everyone is desperate to find ways to reduce the carnage of the opioid epidemic, and everyone has a sense of urgency about this," said Pollack, the Helen Ross Professor at the School of Social Service Administration. "It’s a humbling responsibility to be given this resource."

The Justice Community Opioid Innovation Network grant is part of the  National Institutes of Health’s Helping to End Addiction Long-term initiative , an aggressive, trans-agency effort to speed scientific solutions to stem the national opioid public health crisis. Launched in April 2018, the NIH HEAL Initiative is focused on improving prevention and treatment strategies for opioid misuse and addiction and enhancing pain management.

At UChicago, Schneider and Pollack will oversee nearly a dozen research sites conducting opioid overdose prevention studies on people transitioning through the criminal justice system. The research sites, which are mainly comprised of other academic medical institutions, will collaborate with at least six criminal justice entities and programs across the United States, including prisons, parole and reentry systems, and community-based treatment providers, to improve treatments for opioid addiction as well as pain management.

Schneider directs  The Chicago Center for HIV Elimination , where he researches and implements ways to use existing social networks and public health systems to prevent the spread of HIV. He has used modeling to establish treatment and prevention plans for the state’s ending HIV program,  Getting to Zero Illinois. Pollack co-founded the  University of Chicago Crime Lab  and is the faculty co-director of the  University of Chicago Health Lab. He helps conduct research on interventions to reduce violence and public health challenges on a local and national level.

Argonne, NORC part of collaboration

The UChicago team will provide support in several areas, including storing the various studies’ large quantities of data, which will involve sensitive de-identified patient information.

Researchers at the U.S. Department of Energy’s  Argonne National Laboratory , which is affiliated with the University of Chicago, will be tapped to use simulations and other predictive modeling to gauge the effectiveness of the specific interventions being studied.

"We’ll be combining both our existing computational resources and the dynamic modelling capabilities we’ve developed over the years to look at a variety of interventions," said  Jonathan Ozik, a computational scientist at Argonne.

Meanwhile, the non-partisan research institute  NORC at the University of Chicago  will conduct polling about, and track and analyze policies on, opioid use across the country. The UChicago team also will provide administrative support for the extensive, multi-institution undertaking.

UChicago will serve as one of the research sites and will conduct randomized trials about opioid overdose prevention on people in the criminal justice system at five sites in Illinois, including several jails across the state.

--Adapted from a story that first appeared on the UChicago Medicine website.

interdisciplinary discourse

Newest public art on campus is ’meant to get in your way’

Nubia: Land of the Bow

10:30 AM

Oriental Institute

Science of cities

How city planning can consider nature’s impact on mental health

Only at UChicago

"As long I have all my marbles, I’ll be telling stories in one medium or another."
--Ron McAdow, AB’71

Big Questions

UChicago jumpstarts collaborations with national labs in AI, quantum

Urban policy

How policies can create a more equitable city

Faculty experts

Prof. Tomas J. Philipson to lead White House Council of Economic Advisers

Obituary

John Paul Stevens, Supreme Court justice and UChicago alum, 1920-2019

Argonne

Personalized medicine with high-performance computing

Military community

Veterans learn kayaking on flat waters of UChicago pool

pioneering geology

50 years later, scientists continue to decode moon’s mysteries


This site uses cookies and analysis tools to improve the usability of the site. More information. |